Literature DB >> 1741393

Mouse model of neurodegeneration: atrophy of basal forebrain cholinergic neurons in trisomy 16 transplants.

D M Holtzman1, Y W Li, S J DeArmond, M P McKinley, F H Gage, C J Epstein, W C Mobley.   

Abstract

Vulnerability of specific brain regions and neuronal populations is a characteristic feature of Alzheimer disease and Down syndrome. Cholinergic neurons of the basal forebrain degenerate in both disorders. The basis for neuronal degeneration is unknown. Mouse trisomy 16 (Ts 16) is an animal model of Down syndrome. We sought an experimental system in which the survival and development of Ts 16 basal forebrain cholinergic neurons could be examined beyond the fetal period. As Ts 16 mice do not survive birth, we transplanted fetal Ts 16 and control basal forebrain into the hippocampus of young adult mice. Transplanted neurons survived and grew neurites in all grafts. Over time, we observed selective atrophy of cholinergic neurons in Ts 16 grafts. Denervation of the hippocampus produced a significant increase in the size of Ts 16 cholinergic neurons. This suggests that hippocampal-derived neurotrophic factors acted to prevent degeneration. beta/A4-amyloid-containing plaques were not seen. Ts 16 provides a model of spontaneous, genetically determined neurodegeneration that may be used to understand better the molecular pathogenesis of neuronal dysfunction in Alzheimer disease and Down syndrome.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1741393      PMCID: PMC48455          DOI: 10.1073/pnas.89.4.1383

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

Review 1.  Molecular genetic approaches to Alzheimer's disease.

Authors:  R E Tanzi; P H St George-Hyslop; J F Gusella
Journal:  Trends Neurosci       Date:  1989-04       Impact factor: 13.837

Review 2.  Down syndrome, Alzheimer's disease and the trisomy 16 mouse.

Authors:  J T Coyle; M L Oster-Granite; R H Reeves; J D Gearhart
Journal:  Trends Neurosci       Date:  1988-09       Impact factor: 13.837

Review 3.  New perspectives on Alzheimer's disease.

Authors:  D L Price
Journal:  Annu Rev Neurosci       Date:  1986       Impact factor: 12.449

Review 4.  Alzheimer's disease.

Authors:  R Katzman
Journal:  N Engl J Med       Date:  1986-04-10       Impact factor: 91.245

5.  NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression.

Authors:  P C Maisonpierre; L Belluscio; B Friedman; R F Alderson; S J Wiegand; M E Furth; R M Lindsay; G D Yancopoulos
Journal:  Neuron       Date:  1990-10       Impact factor: 17.173

6.  Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.

Authors:  B Rumble; R Retallack; C Hilbich; G Simms; G Multhaup; R Martins; A Hockey; P Montgomery; K Beyreuther; C L Masters
Journal:  N Engl J Med       Date:  1989-06-01       Impact factor: 91.245

7.  Abnormalities of the nucleus basalis in Down's syndrome.

Authors:  M F Casanova; L C Walker; P J Whitehouse; D L Price
Journal:  Ann Neurol       Date:  1985-09       Impact factor: 10.422

8.  Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome.

Authors:  K E Wisniewski; H M Wisniewski; G Y Wen
Journal:  Ann Neurol       Date:  1985-03       Impact factor: 10.422

9.  Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Authors:  C L Masters; G Simms; N A Weinman; G Multhaup; B L McDonald; K Beyreuther
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

10.  Enhanced graft survival in the hippocampus following selective denervation.

Authors:  F H Gage; A Björklund
Journal:  Neuroscience       Date:  1986       Impact factor: 3.590

View more
  15 in total

1.  Perinatal choline supplementation improves cognitive functioning and emotion regulation in the Ts65Dn mouse model of Down syndrome.

Authors:  Jisook Moon; May Chen; Shruti U Gandhy; Myla Strawderman; David A Levitsky; Kenneth N Maclean; Barbara J Strupp
Journal:  Behav Neurosci       Date:  2010-06       Impact factor: 1.912

2.  Cerebral cortical astroglia from the trisomy 16 mouse, a model for down syndrome, produce neuronal cholinergic deficits in cell culture.

Authors:  P G Nelson; S Fitzgerald; S I Rapoport; E A Neale; Z Galdzicki; V Dunlap; L Bowers; D v Agoston
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

3.  Maternal Choline Supplementation: A Potential Prenatal Treatment for Down Syndrome and Alzheimer's Disease.

Authors:  Barbara J Strupp; Brian E Powers; Ramon Velazquez; Jessica A Ash; Christy M Kelley; Melissa J Alldred; Myla Strawderman; Marie A Caudill; Elliott J Mufson; Stephen D Ginsberg
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

Review 4.  Probing modifications of the neuronal cytoskeleton.

Authors:  L C Doering
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

Review 5.  Neurotrophic factors and neurologic disease.

Authors:  D M Holtzman; W C Mobley
Journal:  West J Med       Date:  1994-09

6.  Cystatin C prevents neuronal loss and behavioral deficits via the endosomal pathway in a mouse model of down syndrome.

Authors:  Gurjinder Kaur; Sebastien A Gauthier; Rocio Perez-Gonzalez; Monika Pawlik; Amol Bikram Singh; Benjamin Cosby; Panaiyur S Mohan; John F Smiley; Efrat Levy
Journal:  Neurobiol Dis       Date:  2018-09-01       Impact factor: 5.996

7.  Selective degeneration fo Purkinje cells with Lewy body-like inclusions in aged NFHLACZ transgenic mice.

Authors:  P H Tu; K A Robinson; F de Snoo; J Eyer; A Peterson; V M Lee; J Q Trojanowski
Journal:  J Neurosci       Date:  1997-02-01       Impact factor: 6.167

Review 8.  Mouse-based genetic modeling and analysis of Down syndrome.

Authors:  Zhuo Xing; Yichen Li; Annie Pao; Abigail S Bennett; Benjamin Tycko; William C Mobley; Y Eugene Yu
Journal:  Br Med Bull       Date:  2016-10-27       Impact factor: 4.291

9.  Maternal choline supplementation improves spatial mapping and increases basal forebrain cholinergic neuron number and size in aged Ts65Dn mice.

Authors:  Jessica A Ash; Ramon Velazquez; Christy M Kelley; Brian E Powers; Stephen D Ginsberg; Elliott J Mufson; Barbara J Strupp
Journal:  Neurobiol Dis       Date:  2014-06-14       Impact factor: 5.996

10.  Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome.

Authors:  Ramon Velazquez; Jessica A Ash; Brian E Powers; Christy M Kelley; Myla Strawderman; Zoe I Luscher; Stephen D Ginsberg; Elliott J Mufson; Barbara J Strupp
Journal:  Neurobiol Dis       Date:  2013-04-30       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.